More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

L Kandolf Sekulovic; K Peris; A Hauschild; A Stratigos; JJ Grob; P Nathan; R Dummer; AM Forsea; C Hoeller; H Gogas; L Demidov; C Lebbe; C Blank; J Olah; L Bastholt; D Herceg; B Neyns; R Vieira; J Hansson; P Rutkowski; I Krajsova; M Bylaite-Bucinskiene; Iris Zalaudek; J Maric-Brozic; N Babovic; M Banjin; K Putnik; G Weinlich; V Todorovic; K Kirov; J Ocvirk; A Zhukavets; M Kukushkina; L De La Cruz Merino; A Ymeri; M Risteski; C Garbe

doi:10.1016/j.ejca.2017.01.012

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

L Kandolf Sekulovic
, K Peris
, A Hauschild
, A Stratigos
, JJ Grob
, P Nathan
, R Dummer
, AM Forsea
, C Hoeller
, H Gogas
, L Demidov
, C Lebbe
, C Blank
, J Olah
, L Bastholt
, D Herceg
, B Neyns
, R Vieira
, J Hansson
, P Rutkowski

I Krajsova, M Bylaite-Bucinskiene, Iris Zalaudek, J Maric-Brozic, N Babovic, M Banjin, K Putnik, G Weinlich, V Todorovic, K Kirov, J Ocvirk, A Zhukavets, M Kukushkina, L De La Cruz Merino, A Ymeri, M Risteski, C Garbe

Universitätsklinik für Dermatologie und Venerologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

38 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	European Journal of Cancer
DOIs	https://doi.org/10.1016/j.ejca.2017.01.012
Publikationsstatus	Veröffentlicht - 2017

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302 Klinische Medizin

Forschungsfelder

Krebsforschung

Zugriff auf Dokument

10.1016/j.ejca.2017.01.012

Andere Dateien und Links

Dieses zitieren

Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, JJ., Nathan, P., Dummer, R., Forsea, AM., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., ... Garbe, C. (2017). More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2017.01.012

@article{7817b2b09e5840d5939f2e49380a689d,

title = "More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.",

author = "\{Kandolf Sekulovic\}, L and K Peris and A Hauschild and A Stratigos and JJ Grob and P Nathan and R Dummer and AM Forsea and C Hoeller and H Gogas and L Demidov and C Lebbe and C Blank and J Olah and L Bastholt and D Herceg and B Neyns and R Vieira and J Hansson and P Rutkowski and I Krajsova and M Bylaite-Bucinskiene and Iris Zalaudek and J Maric-Brozic and N Babovic and M Banjin and K Putnik and G Weinlich and V Todorovic and K Kirov and J Ocvirk and A Zhukavets and M Kukushkina and \{De La Cruz Merino\}, L and A Ymeri and M Risteski and C Garbe",

year = "2017",

doi = "10.1016/j.ejca.2017.01.012",

language = "English",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, JJ, Nathan, P, Dummer, R, Forsea, AM, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M & Garbe, C 2017, 'More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.', European Journal of Cancer. https://doi.org/10.1016/j.ejca.2017.01.012

TY - JOUR

T1 - More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

AU - Kandolf Sekulovic, L

AU - Peris, K

AU - Hauschild, A

AU - Stratigos, A

AU - Grob, JJ

AU - Nathan, P

AU - Dummer, R

AU - Forsea, AM

AU - Hoeller, C

AU - Gogas, H

AU - Demidov, L

AU - Lebbe, C

AU - Blank, C

AU - Olah, J

AU - Bastholt, L

AU - Herceg, D

AU - Neyns, B

AU - Vieira, R

AU - Hansson, J

AU - Rutkowski, P

AU - Krajsova, I

AU - Bylaite-Bucinskiene, M

AU - Zalaudek, Iris

AU - Maric-Brozic, J

AU - Babovic, N

AU - Banjin, M

AU - Putnik, K

AU - Weinlich, G

AU - Todorovic, V

AU - Kirov, K

AU - Ocvirk, J

AU - Zhukavets, A

AU - Kukushkina, M

AU - De La Cruz Merino, L

AU - Ymeri, A

AU - Risteski, M

AU - Garbe, C

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000399856400040

UR - https://pubmed.ncbi.nlm.nih.gov/28264791

U2 - 10.1016/j.ejca.2017.01.012

DO - 10.1016/j.ejca.2017.01.012

M3 - Research article

C2 - 28264791

SN - 0959-8049

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -